LOX1 mRNA in macrophages exposed to 10% plasma obtained from SLE subjects post-placebo-treatment and 10% plasma obtained from SLE subjects post-atorvastatin treatment showed no change at 0.92 (95% CI(0.64 to 1.34)) and 1.07 (95% CI (0.69 to 1.68), Finteraction (1, 32) = 0.414, p = 0.53; Figure 4) compared to cells exposed to respective pre-treatment plasma set at 1.0. Here, OLR1 is linked to systemic lupus erythematosus.